Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus

Recent genome-wide association studies (GWAS) have identified multiple new loci which appear to alter coronary artery disease (CAD) risk via arterial wall-specific mechanisms. One of the annotated genes encodes LMOD1 (Leiomodin 1), a member of the actin filament nucleator family that is highly enriched in smooth muscle-containing tissues such as the artery wall. However, it is still unknown whether LMOD1 is the causal gene at this locus and also how the associated variants alter LMOD1 expression/function and CAD risk. Using epigenomic profiling we recently identified a non-coding regulatory variant, rs34091558, which is in tight linkage disequilibrium (LD) with the lead CAD GWAS variant, rs2820315. Herein we demonstrate through expression quantitative trait loci (eQTL) and statistical fine-mapping in GTEx, STARNET, and human coronary artery smooth muscle cell (HCASMC) datasets, rs34091558 is the top regulatory variant for LMOD1 in vascular tissues. Position weight matrix (PWM) analyses identify the protective allele rs34091558-TA to form a conserved Forkhead box O3 (FOXO3) binding motif, which is disrupted by the risk allele rs34091558-A. FOXO3 chromatin immunoprecipitation and reporter assays show reduced FOXO3 binding and LMOD1 transcriptional activity by the risk allele, consistent with effects of FOXO3 downregulation on LMOD1. LMOD1 knockdown results in increased proliferation and migration and decreased cell contraction in HCASMC, and immunostaining in atherosclerotic lesions in the SMC lineage tracing reporter mouse support a key role for LMOD1 in maintaining the differentiated SMC phenotype. These results provide compelling functional evidence that genetic variation is associated with dysregulated LMOD1 expression/function in SMCs, together contributing to the heritable risk for CAD.

[1]  A. Kostyukova,et al.  Leiomodin-2 is an antagonist of tropomodulin-1 at the pointed end of the thin filaments in cardiac muscle , 2010, Journal of Cell Science.

[2]  Clint L. Miller,et al.  Dissecting the Causal Genetic Mechanisms of Coronary Heart Disease , 2014, Current Atherosclerosis Reports.

[3]  Clint L. Miller,et al.  Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. , 2014, The Journal of clinical investigation.

[4]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[5]  Marc D. Perry,et al.  ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia , 2012, Genome research.

[6]  Ayellet V. Segrè,et al.  Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease , 2015 .

[7]  E. Coligan Current protocols in immunology , 1991 .

[8]  P. Seshiah,et al.  Phosphoinositide-Dependent Kinase 1 and p21-Activated Protein Kinase Mediate Reactive Oxygen Species–Dependent Regulation of Platelet-Derived Growth Factor–Induced Smooth Muscle Cell Migration , 2004, Circulation research.

[9]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[10]  Xin Chen,et al.  The TRANSFAC system on gene expression regulation , 2001, Nucleic Acids Res..

[11]  Tom Michoel,et al.  Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases , 2016, Science.

[12]  S. Gabriel,et al.  Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. , 2014, The Journal of clinical investigation.

[13]  J. Miano,et al.  Leiomodin 1, a New Serum Response Factor-dependent Target Gene Expressed Preferentially in Differentiated Smooth Muscle Cells* , 2011, The Journal of Biological Chemistry.

[14]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[15]  David J. Arenillas,et al.  JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework , 2017, Nucleic acids research.

[16]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[17]  E. Eskin,et al.  Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies , 2014, PLoS genetics.

[18]  J. Danesh,et al.  Association analyses based on false discovery rate implicate new loci for coronary artery disease , 2017, Nature Genetics.

[19]  C. Conley Leiomodin and tropomodulin in smooth muscle. , 2001, American journal of physiology. Cell physiology.

[20]  Ahmed Essaghir,et al.  The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors* , 2009, Journal of Biological Chemistry.

[21]  Ayellet V. Segrè,et al.  Integrative Genomics Reveals Novel Molecular Pathways and Gene Networks for Coronary Artery Disease , 2014, PLoS genetics.

[22]  Clint L. Miller,et al.  Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap , 2015, PLoS genetics.

[23]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[24]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[25]  Lorna M. Lopez,et al.  Genome-wide association studies identify genetic loci for low von Willebrand factor levels , 2015, European Journal of Human Genetics.

[26]  V. Fowler,et al.  Leiomodins: larger members of the tropomodulin (Tmod) gene family. , 2001, Genomics.

[27]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[28]  A. Kundaje,et al.  Characterization of the direct targets of FOXO transcription factors throughout evolution , 2016, Aging cell.

[29]  Mark I. McCarthy,et al.  A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease , 2011, Nature Genetics.

[30]  M. Lupien,et al.  Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits , 2014, Genome research.

[31]  He Zhang,et al.  Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease , 2017, Journal of the American College of Cardiology.

[32]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[33]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[34]  P. Tsao,et al.  Apelin is necessary for the maintenance of insulin sensitivity. , 2009, American journal of physiology. Endocrinology and metabolism.

[35]  D. Rajpal,et al.  Network-Based Identification and Prioritization of Key Regulators of Coronary Artery Disease Loci , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[36]  F. A. Kolpakov,et al.  HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis , 2017, Nucleic Acids Res..

[37]  A. Gabrielsen,et al.  Gene expression signatures, pathways and networks in carotid atherosclerosis , 2016, Journal of internal medicine.

[38]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[39]  Clint L. Miller,et al.  Characterization of TCF21 Downstream Target Regions Identifies a Transcriptional Network Linking Multiple Independent Coronary Artery Disease Loci , 2015, PLoS genetics.

[40]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[41]  Laura S. Shankman,et al.  Correction: Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis , 2015, Nature Medicine.

[42]  Matti Pirinen,et al.  FINEMAP: efficient variable selection using summary data from genome-wide association studies , 2015, bioRxiv.

[43]  D. Tibboel,et al.  Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice , 2017, Proceedings of the National Academy of Sciences.

[44]  R. Virmani,et al.  CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels. , 2016, Circulation research.

[45]  M. Peach,et al.  Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. , 1992, Circulation research.

[46]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[47]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[48]  Valentina Paloschi,et al.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Clint L. Miller,et al.  Coronary Heart Disease-Associated Variation in TCF21 Disrupts a miR-224 Binding Site and miRNA-Mediated Regulation , 2014, PLoS genetics.

[50]  Warren Strober,et al.  Trypan Blue Exclusion Test of Cell Viability , 2001, Current protocols in immunology.

[51]  Andrew D. Johnson,et al.  Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms , 2017, Nature Genetics.

[52]  Claude Bouchard,et al.  Genome-wide physical activity interactions in adiposity. A meta-analysis of 200,452 adults , 2017 .

[53]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[54]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[55]  T. Pollard,et al.  Leiomodin Is an Actin Filament Nucleator in Muscle Cells , 2008, Science.

[56]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[57]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[58]  Trieu Nguyen,et al.  Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci , 2016, Nature Communications.

[59]  Manolis Kellis,et al.  ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.

[60]  Laura S. Shankman,et al.  Activation of the ESC pluripotency factor OCT4 in smooth muscle cells is atheroprotective , 2016, Nature Medicine.

[61]  Ling V. Sun,et al.  Leiomodin-3-deficient mice display nemaline myopathy with fast-myofiber atrophy , 2015, Disease Models & Mechanisms.